Terms: = Liver cancer AND ACVR1, SKR1, 90, ENSG00000115170, Q04771, ACVRLK2, FOP, ALK2, ACTRI AND Treatment
4425 results:
1. Feasibility, safety, efficacy and potential scaling-up of sofosbuvir-based HCV treatment in Central and West Africa: (TAC ANRS 12311 trial).
Lacombe K; Moh R; Chazallon C; Lemoine M; Sylla B; Fadiga F; Le Carrou J; Marcellin F; Kouanfack C; Ciaffi L; Sartre MT; Sida MB; Diallo A; Gozlan J; Seydi M; Cissé V; Danel C; Girard PM; Toni TD; Minga A; Boyer S; Carrieri P; Attia A;
Sci Rep; 2024 May; 14(1):10244. PubMed ID: 38702350
[TBL] [Abstract] [Full Text] [Related]
2. Predictive factors of 90-day mortality after curative hepatic resection for hepatocellular carcinoma: a western single-center observational study.
Vaghiri S; Lehwald-Tywuschik N; Prassas D; Safi SA; Kalmuk S; Knoefel WT; Dizdar L; Alexander A
Langenbecks Arch Surg; 2024 May; 409(1):149. PubMed ID: 38698255
[TBL] [Abstract] [Full Text] [Related]
3. A retrospective clinical analysis of 11 cases of PEComa from different sites.
Yan J; Zhou D; Wang Y; Yang B; Wang Y; Zhang K; Zhang S; Zhang B; Meng Q; Lv Q
World J Surg Oncol; 2024 Apr; 22(1):116. PubMed ID: 38689335
[TBL] [Abstract] [Full Text] [Related]
4. A Comparative Analysis of Implant-sparing Plan
Onal C; Bozca R; Dolek Y; Elmali A; Guler OC
In Vivo; 2024; 38(3):1412-1420. PubMed ID: 38688603
[TBL] [Abstract] [Full Text] [Related]
5. Effectiveness and Safety of Radiofrequency Ablation versus liver Resection in the treatment of Early-stage Hepatocellular Carcinoma: A Systematic Review and Meta-analysis.
Xu Z; Hu Y; Huang L
Ann Ital Chir; 2024; 95(2):109-118. PubMed ID: 38684504
[TBL] [Abstract] [Full Text] [Related]
6. Retrospective analysis of the incidence of appendiceal neoplasm and malignancy in patients treated for suspected acute appendicitis.
Dohner E; Kierdorf FJ; Langer R; Zuber M; Fahrner R
BMC Surg; 2024 Apr; 24(1):121. PubMed ID: 38658891
[TBL] [Abstract] [Full Text] [Related]
7. Efficacy and safety of tislelizumab plus lenvatinib as first-line treatment in patients with unresectable hepatocellular carcinoma: a multicenter, single-arm, phase 2 trial.
Xu L; Chen J; Liu C; Song X; Zhang Y; Zhao H; Yan S; Jia W; Wu Z; Guo Y; Yang J; Gong W; Ma Y; Yang X; Gao Z; Zhang N; Zheng X; Li M; Su D; Chen M
BMC Med; 2024 Apr; 22(1):172. PubMed ID: 38650037
[TBL] [Abstract] [Full Text] [Related]
8. [Long-term outcome of patients with rectal cancer who achieve complete or near complete clinical responses after neoadjuvant therapy: a multicenter registry study of data from the Chinese Watch and Wait Database].
Zhao YM; Wang WH; Zhang W; Wang L; Li S; Wang JW; Liao LE; Yu GY; Sun Z; Qu YL; Gong Y; Lu Y; Wu T; Li YF; Wang Q; Zhao GH; Xiao Y; Ding PR; Zhang Z; Wu AW
Zhonghua Wei Chang Wai Ke Za Zhi; 2024 Apr; 27(4):372-382. PubMed ID: 38644243
[No Abstract] [Full Text] [Related]
9. The Role of microRNAs in Hepatocellular cancer: A Narrative Review Focused on Tumor Microenvironment and Drug Resistance.
Tavakoli Pirzaman A; Alishah A; Babajani B; Ebrahimi P; Sheikhi SA; Moosaei F; Salarfar A; Doostmohamadian S; Kazemi S
Technol Cancer Res Treat; 2024; 23():15330338241239188. PubMed ID: 38634139
[TBL] [Abstract] [Full Text] [Related]
10. Preparation and Evaluation of Chitosan Coated PLGA Nanoparticles Encapsulating Ivosidenib with Enhanced Cytotoxicity Against Human liver cancer Cells.
Alsulays BB; Aodah AH; Ahmed MM; Anwer MK
Int J Nanomedicine; 2024; 19():3461-3473. PubMed ID: 38617799
[TBL] [Abstract] [Full Text] [Related]
11. Hepatic arterial infusion pump chemotherapy combined with systemic chemotherapy for borderline resectable and unresectable colorectal liver metastases: phase II feasibility study.
Krul MF; Kok NFM; Osmani H; Buisman FE; Groot Koerkamp B; Grunhagen DJ; Verhoef C; Mostert B; Snaebjornsson P; Westerink B; Klompenhouwer EG; Donswijk ML; Ruers TJM; Douma JAJ; van Blijderveen N; Kingham TP; D'Angelica MI; Kemeny NE; Bolhuis K; Buffart TE; Kuhlmann KFD
Br J Surg; 2024 Apr; 111(4):. PubMed ID: 38608150
[TBL] [Abstract] [Full Text] [Related]
12. Troponin Elevation in Patients Undergoing Percutaneous Hepatic Perfusion for Metastatic Uveal Melanoma.
Chandrasekhar S; Perez M; Niaz Z; Ekram J; Lal N; Koly S; Cao B; Zager JS; Alomar M
Cancer Control; 2024; 31():10732748241246898. PubMed ID: 38605434
[TBL] [Abstract] [Full Text] [Related]
13. Assessment of disease control rate and safety of sorafenib in targeted therapy for advanced liver cancer.
Zeng D; Yu C; Chen S; Zou L; Chen J; Xu L
World J Surg Oncol; 2024 Apr; 22(1):93. PubMed ID: 38605359
[TBL] [Abstract] [Full Text] [Related]
14. Multiscale and multiperception feature learning for pancreatic lesion detection based on noncontrast CT.
Yan T; Tang G; Zhang H; Liang L; Ma J; Gao Y; Zhou C; Li S
Phys Med Biol; 2024 May; 69(10):. PubMed ID: 38588676
[No Abstract] [Full Text] [Related]
15. UBE2C: A pan-cancer diagnostic and prognostic biomarker revealed through bioinformatics analysis.
Jalali P; Samii A; Rezaee M; Shahmoradi A; Pashizeh F; Salehi Z
Cancer Rep (Hoboken); 2024 Apr; 7(4):e2032. PubMed ID: 38577722
[TBL] [Abstract] [Full Text] [Related]
16. Comparison of Four Diagnostic Guidelines for Hepatocellular Carcinoma Using Gadoxetic Acid-enhanced liver MRI.
Yoon JH; Kim YK; Kim JW; Chang W; Choi JI; Park BJ; Choi JY; Kim SS; Park HS; Lee ES; Yu JS; Park SJ; You MW; Lee CH; Lee JM
Radiology; 2024 Apr; 311(1):e233114. PubMed ID: 38563667
[TBL] [Abstract] [Full Text] [Related]
17. Cyanide-Isolated Cobalt Catalyst for Ultraefficient Advanced Oxidation treatment.
Zheng J; Zhang S
Environ Sci Technol; 2024 Apr; 58(14):6444-6454. PubMed ID: 38551318
[TBL] [Abstract] [Full Text] [Related]
18. Atezolizumab plus modified docetaxel, cisplatin, and fluorouracil as first-line treatment for advanced anal cancer (SCARCE C17-02 PRODIGE 60): a randomised, non-comparative, phase 2 study.
Kim S; Ghiringhelli F; de la Fouchardière C; Evesque L; Smith D; Badet N; Samalin E; Lopez-Trabada Ataz D; Parzy A; Desramé J; Baba Hamed N; Buecher B; Tougeron D; Bouché O; Dahan L; Chibaudel B; El Hajbi F; Mineur L; Dubreuil O; Ben Abdelghani M; Pecout S; Bibeau F; Herfs M; Garcia ML; Meurisse A; Vernerey D; Taïeb J; Borg C
Lancet Oncol; 2024 Apr; 25(4):518-528. PubMed ID: 38547895
[TBL] [Abstract] [Full Text] [Related]
19. Extended Right Hepatectomy following Clearance of the Left liver Lobe and Portal Vein Embolization for Curatively Intended treatment of Extensive Bilobar Colorectal liver Metastases: A Single-Center Case Series.
Knitter S; Sauer L; Hillebrandt KH; Moosburner S; Fehrenbach U; Auer TA; Raschzok N; Lurje G; Krenzien F; Pratschke J; Schöning W
Curr Oncol; 2024 Feb; 31(3):1145-1161. PubMed ID: 38534918
[TBL] [Abstract] [Full Text] [Related]
20. The efficacy and safety of PD-1 inhibitor combined with TACE in the first-line treatment of unresectable hepatocellular carcinoma.
Liu QQ; Wang XX; Ji H; Dou QY; Zhang HM
Med Oncol; 2024 Mar; 41(5):91. PubMed ID: 38526607
[TBL] [Abstract] [Full Text] [Related]
[Next]
